AdaptHealth Corp. (AHCO) Comparison with companies in other sectors?

AdaptHealth Corp. has a share price of 134.95M. You can analyze AdaptHealth Corp. (AHCO) competitors across different market sectors through stock heatmaps.

What are AHCO's NET and operating margins?

AdaptHealth Corp. (AHCO) operating margin is around 0.08, and net profit margin is approximately 0.03 as of the latest reports.

In what way does AHCO's earnings per share (EPS) trend reflect its financial momentum?

AdaptHealth Corp. (AHCO) EPS is 0.58 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for AdaptHealth Corp. is 16.28, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for AdaptHealth Corp.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for AdaptHealth Corp. like P/E which is 14.92, P/B which is 0.81, and PEG which is -3.03. Compare them with sector averages to evaluate if the stock is priced fairly.

AdaptHealth Corp.

AHCO•NASDAQ

Healthcare

Medical - Devices

$9.44

$0.22(2.39%)

Fundamental Analysis of AdaptHealth Corp. (AHCO)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.58

P/E Ratio

16.28

ROE

0.06%

Net Margin

0.03%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.27B

Shares OutstandingTotal number of shares issued

$134.95M

Book Value/ShareNet worth per share

$11.68

Revenue/ShareAnnual revenue per share

$22.62

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.58

Net MarginNet income as percentage of revenue

2.80%

Operating MarginOperating income as percentage of revenue

7.97%

ROEReturn on shareholders' equity

5.56%

ROAReturn on total assets

1.92%

ROCEReturn on capital employed

6.29%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.04

Cash/ShareCash and equivalents per share

$0.40

FCF YieldFree cash flow as percentage of market cap

21.50%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for AHCOFinancial Ratios Analysis details for AHCO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AHCOSector Benchmarking details for AHCO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for AdaptHealth Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of AdaptHealth Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account AdaptHealth Corp.'s unique business strengths and challenges.

Key Financial Metrics for AdaptHealth Corp.

For AdaptHealth Corp., essential financial indicators include EPS 0.58, PE 16.28, and ROE 0.06. These key ratios reveal insights into AdaptHealth Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare AdaptHealth Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of AdaptHealth Corp.

Metrics like Net Margin 2.80% and ROA 1.92% shed light on how well AdaptHealth Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether AdaptHealth Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of AdaptHealth Corp.

Using ratios such as P/B Ratio 0.81 and PEG Ratio -3.03, investors can assess whether AdaptHealth Corp. is appropriately valued based on its financials and growth potential. These figures, combined with AdaptHealth Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for AdaptHealth Corp.

Financial health indicators, such as Debt/Equity Ratio 1.34 and Cash Flow $2.04, provide a snapshot of AdaptHealth Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like AdaptHealth Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for AdaptHealth Corp.

Investing in AdaptHealth Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at AdaptHealth Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;